# Sutro Biopharma (STRO) — Overview

STRO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/stro

## Price

Last close $11.60 on Oct 15, 2026. 52-week range $7.30 – $40.91.

## Company profile

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $45.7M |
| Revenue (quarter) | $9.8M |
| Revenue growth (year over year) | -84.57% |
| Gross profit (trailing twelve months) | $45.7M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$180.6M |
| Net income (quarter) | −$38.5M |
| Net income growth (year over year) | -235.10% |
| Net margin | -395.25% |
| Return on equity | 0.00% |
| EPS (trailing twelve months) | −$17.37 |
| Book value per share | −$6.23 |
| P/E (trailing twelve months) | — |
| Price to book | — |
| Debt to assets | 153.13% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Sutro Biopharma (STRO) profitable?

No. Sutro Biopharma reported a net loss of $180.6M over the trailing twelve months.

### How much revenue does Sutro Biopharma (STRO) make?

Sutro Biopharma generated $45.7M in revenue over the trailing twelve months, down 84.57% year over year.

### How do I buy stock in Sutro Biopharma (STRO)?

STRO trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).